Pacing therapy for prevention of atrial fibrillation

Heart Rhythm

Volumn 4, Issue 3 SUPPL., 2007, Pages

  Ellenbogen, Kenneth A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antitachycardia pacing; Atrial fibrillation; Pacemaker; Pacing

Indexed keywords

ACCURACY; ACUTE DISEASE; ALGORITHM; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; DEATH; DISEASE DURATION; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART PACING; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LONG TERM CARE; META ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SINUS NODE DYSFUNCTION; STROKE; SYSTEMATIC REVIEW;

ALGORITHMS; ANIMALS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; EQUIPMENT DESIGN; HEART ATRIA; HEART VENTRICLES; HUMANS; PACEMAKER, ARTIFICIAL; PRACTICE GUIDELINES; SINOATRIAL NODE; TREATMENT OUTCOME; VENTRICULAR FUNCTION;

EID: 33847304109     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2006.12.005     Document Type: Article

References (21)

1. Healey J.S., Toff W.D., Lamas G.A., Andersen H.R., Thorpe K.E., Ellenbogen K.A., Lee K.L., Skene A.M., Schron E.B., Skehan J.D., Goldman L., Roberts R.S., Camm A.J., Yusuf S., and Connolly S.J. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation 114 (2006) 11-17
2. Sweeney M.O., Hellkamp A.S., Ellenbogen K.A., Greenspon A.J., Freedman R.A., Lee K.L., Lamas G.A., and Mode Selection Trial Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy. Circulation 107 (2003) 2931-2937
3. Glotzer T.V., Hellkamp A.S., Zimmerman J., Sweeney M.O., Yee R., Marinchak R., Cook J., Paraschos A., Love J., Radoslovich G., Lee K.L., Lamas G.A., and MOST Investigators. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke. Circulation 107 (2003) 1614-1619
4. Capucci A., Santini M., Padeletti L., Gulizia M., Botto G.L., Borianai G., Ricci R., Favale S., Zolezzi F., Belardino N., Molon G., Drago F., Villani G.Q., Mazzini M.S., Vimercati M., Grammatico A., and Italian AT500 Registry Investigators. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 46 (2005) 1913-1920
5. Hoppe U.C., Casares J.M., Eiskjaer H., Hagemann A., Cleland J.G., Freemantle N., and Erdmann E. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation 114 (2006) 18-25
6. Hohnloser S.H., Capucci A., Fain E., Gold M.R., van Gelder I.C., Healey J., Israel C.W., Lau C.P., Morillo C., Conolly S.J., and ASSERT Investigators. Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT). Am Heart J 152 (2006) 442-447
7. Gillis A.M., Wyse D.G., Connolly S.J., Dubuc M., Philippon F., Yee R., Lacombe P., Rose M.S., and Kerr C.D. Atrial pacing per-ablation for prevention of paroxysmal atrial fibrillation. Circulation 99 (1999) 2553-2558
8. Gillis A.M., Connolly S.J., Lacombe P., Philippon F., Dubuc M., Kerr C.R., Yee R., Rose M.S., Newman D., Kavanagh K.M., Gardner M.J., Kus T., and Wyse D.G. A randomized crossover comparison of DDDR versus VDD pacing for prevention of atrial fibrillation. Circulation 102 (2000) 736-741
9. Carlson M.D., Ip J., Messenger J., Beau S., Kalbfleisch S., Gervais P., Cameron D.A., Duran A., Val-Mejias J., Mackall J., Gold M.R., ADOPT Investigators, and Atrial Dynamic Overdrive Pacing Trial (ADOPT) Investigators. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 42 (2003) 627-633
10. Padeletti L., Purefellner H., Adler S.W., Waller T.J., Harvey M., Horvitz L., Holbrook R., Kempen K., Mugglin A., Hettrick D.A., and Worldwide ASPECT Investigators. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol 14 (2003) 1189-1195
11. Blanc J.J., De Roy L., Mansourati J., Poezevara Y., Marcon J.L., Schoels W., Hidden-Lucet F., Barnay C., and PIPAF Investigators. Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms. Europace 6 (2004) 371-379
12. Knight B.P., Gersh B.J., Carlson M.D., Friedman P.A., McNamara R.L., Strickberger S.A., Tse H.G., and Waldo A.L. Role of permanent pacing to prevent atrial fibrillation. Circulation 111 (2005) 240-243
13. Madan N., and Saksena S. Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual site right atrial pacing, antiarrhythmic drugs, and right atrial ablation. Am J Cardiol 93 (2004) 569-575
14. Bailin S.J., Adler S., and Giudici M. Prevention of chronic atrial fibrillation by pacing in the region of Bachmann's bundle: results of a multicenter randomized trial. J Cardiovasc Electrophysiol 12 (2001) 912-917
15. Padeletti L., Porciani M.C., Michelucci A., Coltella A., Ticci P., Vena S., Costoli A., Ciapetti A., Pieragnoli P., and Gensini G.F. Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation. J Interven Card Electrophysiol 3 (1999) 35-43
16. Hermida J.S., Kubala M., Lescure F.X., Delonca J., Clerc J., Otmani A., Jarry G., and Rey J.L. Atrial septal pacing to prevent atrial fibrillation in patients with sinus node dysfunction: results of a randomized controlled study. Am Heart J 148 (2004) 312-317
17. Friedman P.A., Ip J.H., Jazayeri M., Lobban J.H., Olshansky B., Zhou D., Knowles T., Euler D.E., and RID-AF Investigators. The impact of atrial prevention and termination on atrial tachyarrhythmia burden in patients receiving a dual chamber defibrillator for ventricular arrhythmias. J Interv Card Electrophysiol 10 (2004) 103-110
18. Gulizia M., Mangiameli S., Orazi S., Chiaranda G., Boriani G., Piccione G., DiGiovanni N., Colletti A., Puntrello C., Butera G., Vasco C., Vaccaro I., Scardace G., and Grammatico A. Randomized comparison between ramp and burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDRP device. Europace 8 (2006) 465-473
19. Lee M.A., Weachter R., Pollak S., Kremers M.S., Naik A.M., Silverman R., Tuzi J., Wang W., Johnson L.J., and Euler D.E. ATTEST Investigators: The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial inpatients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 41 (2003) 1926-1932
20. Hoffmann E., Sulke N., Edvardsson N., Ruiter J., Lewalter T., Capucci A., Schuchert A., Janko S., Camm J., and Atrial Fibrillation Therapy (AFT) Trial Investigators. New Insights into the Initiation of atrial fibrillation: A detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. Circulation 113 (2006) 1933-1941
21. Lewalter T., Yank A., Pfeiffer D., Ruiter J., Schnitzler G., Markert T., Asklund M., Przibille O., Welz A., Esmailzadeh B., Linhart M., and Luderitz B. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: Results from the VIP Registry. PACE 29 (2006) 124-134